Health
Pfizer-BioNTech set to request approval for worldwide use of its COVID-19 vaccine in children as young as FIVE – 7NEWS.com.au
It has also laid out plans to seek approval in children aged six months to two years.
Pfizer-BioNTech is set to request approval across the globe to use its COVID-19 vaccine in children as young as five over the next few weeks.
Already over the next few weeks we will file the results of our trial in five to 11-year-olds with regulators across…
Continue Reading
-
Noosa News13 hours agoCrucial step in Sea World helicopter crash investigation set
-
Business13 hours agoWhy Accent, DroneShield, EBR Systems, and Titomic shares are pushing higher
-
Noosa News20 hours agoLocal input into new UN treaty – Proctor
-
Business18 hours agoIs the Qantas share price a buy in the tariff ASX stock market volatility?